The radioactively labeled lipid donor nanoparticle was prepared from a lipid mixture described previously by Ginsburg et al. [10] and modified by Maranhão et al. [11]. Two sets of the nanoemulsion were prepared, one labeled with 3H-triglycerides and 14C-cholesterol and the other with 3H-cholesteryl esters and 14C-phospholipids. In a vial, 40 mg cholesteryl oleate, 20 mg egg phosphatidylcholine, 1 mg triolein and 0.5 mg cholesterol, purchased from Sigma Aldrich (St. Louis, MO, USA), were mixed. Trace amounts of glycerol tri [[9, 10](n)-3H] oleate and 4-14C-cholesterol or [1α,2α(n)-3H]-cholesteryl oleate and L-3-phosphatidylcholine,1-stearoyl-2-[1-14C] arachidonyl (Amersham BioSciences, Little Chalfont, Buckinghamshire, UK) were added to the initial solution. The lipids were emulsified by prolonged ultrasonic irradiation in aqueous media for 3 h, and the crude emulsion then ultracentrifugated in a two-step process, with density adjustment by addition of KBr to obtain the nanoparticle. The nanoparticle fraction was dialyzed against a 0.9% NaCl solution.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.